Published Date: 11 Jul 2026
Listener feedback on ICE vs TEE in AF ablation, fractional flow reserve without a wire or catheter, more bad news for ticagrelor, the POLY-HF trial, and oxygen targets after cardiac arrest are the topics John Mandrola, MD, discusses in this week’s podcast.
Read Full News1.
Mental health risk persists years after cancer diagnosis
2.
Breast cancer prevention: How nurse practitioners and physician assistants can help
3.
For treatment, the majority of cancer patients choose complementary therapies.
4.
Cancer mortality continuing to decline, says report
5.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
1.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
2.
Bone Marrow Microenvironment Biomarkers in Hematologic Health
3.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
4.
HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer
5.
The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation